title: Effect of adding selegiline to levodopa in early, mild Parkinson's disease. Evidence is insufficient to show that combined treatment increases mortality.
authors.forename: H
authors.initials: H
authors.lastname: Aaltonen
authors.forename: O
authors.initials: O
authors.lastname: Kilkku
authors.forename: E
authors.initials: E
authors.lastname: Heinonen
authors.forename: O
authors.initials: O
authors.lastname: Mäki-Ikola
mesh_terms: D000978:Antiparkinson Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy*; D012642:Selegiline / Q000627:therapeutic use*; D016019:Survival Analysis; D016896:Treatment Outcome
chemical_list: D000978:Antiparkinson Agents; D004338:Drug Combinations; D012642:Selegiline; D007980:Levodopa